UPF0729 protein C18orf32 homolog Antibody

What is UPF0729 protein C18orf32 and what are its basic structural features?

UPF0729 protein C18orf32 is a small protein encoded by the C18orf32 gene located on chromosome 18 in humans. The canonical protein has a reported length of 76 amino acid residues with a molecular mass of approximately 8.7 kDa. It belongs to the UPF0729 protein family, which has orthologs across multiple species . This protein is notable for its compact size yet potential functional significance in cellular signaling pathways. The protein is localized primarily to the endoplasmic reticulum (ER), suggesting its involvement in ER-associated cellular processes . Despite its small size, C18orf32 contains important structural elements that contribute to its biological activity, particularly in relation to NF-kappa-B pathway activation.

What are the known homologs of C18orf32 across different species?

C18orf32 is evolutionarily conserved with homologs identified in multiple species, including mouse, rat, bovine, frog, zebrafish, chimpanzee, and chicken . In prairie vole (Microtus ochrogaster), the homolog is designated as C18H18orf32, reflecting its chromosomal location . Multiple protein isoforms of the C18H18orf32 homolog have been cataloged with accession numbers including XP_005356325.1, XP_005356327.1, and XP_005356326.1 . The presence of C18orf32 homologs across diverse vertebrate species suggests an evolutionarily conserved function, making comparative studies valuable for understanding its biological significance. Research examining the degree of sequence conservation across species can provide insights into functionally critical domains within the protein.

What are the common synonyms and alternative designations for this protein?

Researchers should be aware of several alternative designations for C18orf32 in the literature and databases:

• Putative NF-kappa-B-activating protein 200

• Putative NFkB activating protein

• UPF0729 protein C18orf32

Understanding these alternative designations is crucial when conducting literature searches or database queries to ensure comprehensive retrieval of relevant research information. When publishing research findings, it is advisable to reference all common synonyms to improve discoverability of your work. The annotation "UPF" (uncharacterized protein family) in the designation UPF0729 indicates that while the protein has been identified, its precise function remained initially uncharacterized, though subsequent research has begun to elucidate its biological roles.

What are the primary applications for C18orf32 antibodies in research?

C18orf32 antibodies have several key applications in molecular and cellular research:

• Western Blot (WB): Used for protein detection and quantification, providing information about molecular weight and expression levels .

• Immunohistochemistry (IHC): Particularly IHC-p (paraffin-embedded) for detecting C18orf32 in tissue sections, allowing localization studies and expression pattern analysis .

• Immunocytochemistry (ICC): For detecting the protein in cultured cells to study subcellular localization .

• Immunofluorescence (IF): Providing high-resolution imaging of protein localization when used with fluorescently-labeled secondary antibodies .

• ELISA: Some antibodies are validated for enzyme-linked immunosorbent assays, particularly those targeting zebrafish homologs .

The selection of the appropriate application depends on the specific research question, with considerations for sensitivity, specificity, and the type of data needed (qualitative vs. quantitative).

How should researchers optimize Western blot protocols for detecting C18orf32?

Given the small size of C18orf32 (8.7 kDa), researchers should implement specific optimizations when performing Western blots:

• Gel percentage: Use high percentage (15-20%) polyacrylamide gels to effectively resolve low molecular weight proteins.

• Transfer conditions: Optimize transfer time and voltage for small proteins - shorter transfer times at higher voltages are often effective for small proteins to prevent over-transfer.

• Blocking conditions: Test different blocking agents (BSA vs. non-fat milk) as milk proteins may sometimes mask detection of small proteins.

• Antibody selection: Choose antibodies validated specifically for Western blot applications, as indicated in antibody product descriptions .

• Loading controls: Select appropriate loading controls of similar molecular weight range for accurate normalization.

• Detection method: Enhanced chemiluminescence (ECL) with longer exposure times may be necessary due to the potentially low expression levels of C18orf32 in some cell types.

Researchers should note that the protein's wide expression across tissue types may require careful consideration of positive and negative controls when developing experimental protocols .

What factors should be considered when selecting a C18orf32 antibody for cross-species studies?

When conducting cross-species studies involving C18orf32, researchers should consider:

• Epitope conservation: Analyze sequence alignment between species to determine the degree of conservation in the epitope region targeted by the antibody.

• Validated reactivity: Select antibodies with experimentally validated cross-reactivity to the species of interest. Commercially available antibodies are typically validated for specific species such as human, mouse, rat, or zebrafish .

• Antibody type selection: For highly conserved regions, monoclonal antibodies may provide consistent results across species. For less conserved regions, species-specific polyclonal antibodies may be necessary.

• Validation methods: Perform preliminary validation using positive and negative controls, including overexpression systems or knockout/knockdown models if available.

• Applications compatibility: Ensure the antibody is validated for your intended application in the target species, as cross-reactivity may vary between applications like Western blot versus immunohistochemistry .

The search results indicate several commercial antibodies available with reactivity to zebrafish C18orf32 homolog as well as human C18orf32, providing options for comparative studies .

What is the evidence for C18orf32's role in the NF-kappa-B signaling pathway?

C18orf32 has been implicated in the activation of the NF-kappa-B signaling pathway, a critical pathway involved in inflammation, immunity, and cell survival. The evidence supporting this role includes:

• Functional annotation: C18orf32 is alternatively known as "putative NF-kappa-B-activating protein 200," suggesting its functional connection to this pathway .

• Cellular localization: Its localization in the endoplasmic reticulum positions it to potentially influence signaling cascades originating from this organelle .

• Protein interactions: While the direct molecular mechanism remains to be fully elucidated, the protein likely interacts with components of the canonical or non-canonical NF-κB pathway.

Researchers investigating this connection should consider:

• Using reporter gene assays (such as luciferase reporters controlled by NF-κB responsive elements) to measure pathway activation in response to C18orf32 manipulation

• Examining phosphorylation status of key NF-κB pathway components (IκB, p65) following C18orf32 overexpression or knockdown

• Investigating potential protein-protein interactions between C18orf32 and known NF-κB pathway components

The relatively recent characterization of this protein presents opportunities for novel discoveries regarding its precise role in NF-κB regulation.

How is C18orf32 expression related to Glycosylphosphatidylinositol biosynthesis defects?

The C18orf32 gene has been associated with Glycosylphosphatidylinositol (GPI) biosynthesis defects , suggesting a potential role in the GPI anchor biosynthetic pathway. GPI anchors are glycolipid structures that anchor various proteins to the cell surface, and defects in this pathway are associated with multiple inherited disorders.

Key considerations for researchers studying this association include:

• Expression correlation: Investigate whether C18orf32 expression levels correlate with the expression of known GPI biosynthesis genes.

• Functional studies: Knockdown or knockout studies can help determine if C18orf32 depletion affects the surface expression of GPI-anchored proteins.

• Biochemical assays: Use techniques such as flow cytometry with fluorescently labeled proaerolysin (FLAER) to assess GPI anchor synthesis in systems with modified C18orf32 expression.

• Clinical correlations: Examine C18orf32 mutations or expression variations in patients with known GPI biosynthesis defects to establish clinical relevance.

• Subcellular localization: Since GPI anchor synthesis occurs in the ER, the localization of C18orf32 to this compartment provides a spatial context for its potential involvement in this process.

This association presents an important direction for researchers investigating inherited GPI biosynthesis disorders or researchers interested in membrane protein trafficking.

What experimental models are most suitable for studying C18orf32 function?

Based on the available information about C18orf32, several experimental models can be considered for functional studies:

• Cell culture models:

  • Human cell lines with documented C18orf32 expression

  • Cell lines relevant to NF-κB signaling pathways (immune cells, epithelial cells)

  • ER stress models to investigate the protein's function in relation to its subcellular localization

• Animal models:

  • Given the presence of orthologs in multiple species including mouse, rat, zebrafish, and others , researchers have options for in vivo studies

  • Zebrafish models may be particularly valuable given the availability of antibodies specifically targeting the zebrafish homolog

  • Genetically modified mouse models (knockout/knockin) can provide insights into physiological functions

• Overexpression and knockdown systems:

  • Transient transfection of tagged C18orf32 constructs for localization and interaction studies

  • CRISPR-Cas9 mediated knockout for loss-of-function studies

  • shRNA or siRNA approaches for transient knockdown experiments

• In vitro biochemical systems:

  • Reconstituted systems for studying potential enzymatic activities

  • Protein-protein interaction studies using purified components

The choice of model system should be guided by the specific research question and the tools available for detecting the protein, with consideration for the endogenous expression levels in different tissue types .

What strategies can be employed to investigate potential post-translational modifications of C18orf32?

Given the protein's small size and potential regulatory functions, post-translational modifications (PTMs) may be critical for C18orf32 function. Researchers can employ these strategies to investigate PTMs:

• Mass spectrometry approaches:

  • Tandem MS for identification of specific modification sites

  • SILAC (Stable Isotope Labeling with Amino acids in Cell culture) to quantify changes in modification status under different conditions

  • Enrichment strategies specific to modifications of interest (phosphorylation, ubiquitination, etc.)

• Biochemical approaches:

  • Phospho-specific antibodies if phosphorylation sites are identified

  • Mobility shift assays to detect modifications that alter electrophoretic mobility

  • Chemical treatments that remove specific modifications (phosphatases, deubiquitinases)

• Site-directed mutagenesis:

  • Mutation of potential modification sites to assess functional consequences

  • Creation of phosphomimetic mutations to study functional effects

• In silico analysis:

  • Computational prediction of potential modification sites based on consensus sequences

  • Structural modeling to assess accessibility of potential modification sites

The small size of C18orf32 (76 amino acids) means that even a few PTMs could significantly impact its structure and function, making this an important avenue for investigation.

How can researchers effectively study protein-protein interactions involving C18orf32?

To investigate the interactome of C18orf32, researchers should consider these methodologies:

• Affinity purification-mass spectrometry (AP-MS):

  • Express tagged (e.g., FLAG, HA, His) versions of C18orf32

  • Perform pull-down experiments followed by MS identification of binding partners

  • Consider both stable and transient interactions through crosslinking approaches

• Proximity labeling techniques:

  • BioID or TurboID fusion proteins to identify proximal proteins in living cells

  • APEX2 proximity labeling for temporal control of labeling reactions

  • These methods are particularly valuable for studying membrane-associated proteins like C18orf32

• Co-immunoprecipitation:

  • Using available antibodies against C18orf32 for endogenous protein studies

  • Verification of specific interactions identified through high-throughput methods

• Yeast two-hybrid screening:

  • For detecting direct binary interactions

  • Consider membrane yeast two-hybrid systems given C18orf32's ER localization

• Fluorescence-based interaction assays:

  • FRET (Förster Resonance Energy Transfer) or BiFC (Bimolecular Fluorescence Complementation) to visualize interactions in living cells

  • Particularly useful for confirming interactions in the native cellular environment

When designing interaction studies, researchers should consider the protein's endoplasmic reticulum localization and potential role in NF-κB signaling to guide the selection of experimental conditions and potential interacting partners to investigate.

What considerations should guide the design of C18orf32 knockout studies?

When designing knockout studies for C18orf32, researchers should address these critical considerations:

• Knockout strategy selection:

  • CRISPR-Cas9 genome editing for complete gene knockout

  • Conditional knockout systems if constitutive knockout proves lethal

  • Inducible knockdown (shRNA/siRNA) for temporal control of expression reduction

• Verification methods:

  • PCR-based genotyping to confirm genomic modifications

  • Western blot using validated antibodies to confirm protein loss

  • RT-qPCR to assess transcript levels

• Phenotypic analysis focus areas:

  • NF-κB pathway activation status, given C18orf32's putative role in this pathway

  • GPI-anchored protein expression, considering the association with GPI biosynthesis defects

  • ER stress responses, based on the protein's subcellular localization

  • Cell viability and proliferation assays to assess fundamental cellular effects

• Species-specific considerations:

  • For mouse models, consider that C18orf32 has orthologs in mice , enabling translational studies

  • For zebrafish models, antibodies specific to the zebrafish homolog are available

• Control selection:

  • Include appropriate wild-type controls

  • Consider rescue experiments with re-expression of C18orf32 to confirm phenotype specificity

  • Use isogenic control cell lines to minimize background genetic variation

The wide tissue expression pattern of C18orf32 suggests potential systemic effects of knockout, requiring comprehensive phenotypic assessment across multiple physiological systems and cell types.

What are the optimal immunohistochemistry protocols for detecting C18orf32 in different tissue types?

Given C18orf32's wide expression across tissue types , researchers should optimize immunohistochemistry (IHC) protocols as follows:

• Tissue preparation considerations:

  • Fixation: For small proteins like C18orf32 (8.7 kDa) , shorter fixation times may improve epitope accessibility

  • Antigen retrieval: Test both heat-induced epitope retrieval (HIER) and enzymatic methods to determine optimal conditions

  • Section thickness: Thinner sections (3-5 μm) may provide better resolution for this small protein

• Antibody selection and optimization:

  • Choose antibodies specifically validated for IHC-p applications

  • Conduct antibody dilution series to determine optimal concentration

  • Consider the use of signal amplification systems (e.g., tyramide signal amplification) if detection sensitivity is limited

• Control samples:

  • Include tissues with known high expression of C18orf32

  • Use blocking peptides for specificity validation

  • Consider tissues from knockout models as negative controls when available

• Detection systems:

  • Chromogenic detection (DAB) for conventional brightfield microscopy

  • Fluorescent detection for co-localization studies with other ER markers

  • Multiplex IHC for correlation with NF-κB pathway components

• Counterstaining:

  • Light hematoxylin counterstaining to avoid obscuring the target signal

  • Nuclear counterstains (DAPI, Hoechst) for fluorescent detection methods

The subcellular localization of C18orf32 to the ER should guide the interpretation of staining patterns, with particular attention to perinuclear reticular patterns characteristic of ER proteins.

How can researchers effectively quantify C18orf32 expression levels across different experimental conditions?

Accurate quantification of C18orf32 expression requires consideration of its small size and potentially variable expression levels. Researchers should employ these strategies:

• Western blot quantification:

  • Use high-percentage gels (15-20%) to resolve the 8.7 kDa protein

  • Select loading controls of similar molecular weight for accurate normalization

  • Employ digital imaging and analysis software with standard curves to ensure linearity of signal

  • Use validated antibodies specifically tested for Western blot applications

• qRT-PCR approaches:

  • Design primers spanning exon-exon junctions to prevent genomic DNA amplification

  • Validate primer efficiency using standard curves

  • Select appropriate reference genes stable under your experimental conditions

  • Consider digital droplet PCR for absolute quantification

• Proteomics quantification:

  • Targeted MS approaches such as selected reaction monitoring (SRM) or parallel reaction monitoring (PRM)

  • SILAC or TMT labeling for relative quantification across conditions

  • Use of internal standard peptides for absolute quantification

• Flow cytometry:

  • For samples amenable to single-cell analysis

  • Requires careful permeabilization protocols to access the ER-localized protein

  • Consider dual staining with ER markers to confirm specificity

• Immunofluorescence with quantitative image analysis:

  • Z-stack imaging to capture the full cellular volume

  • Automated image analysis software for unbiased quantification

  • Single-cell analysis to assess population heterogeneity

For each method, appropriate statistical analysis should be applied, with consideration for the distribution of the data and the experimental design.

What approaches can be used to compare functional conservation of C18orf32 across different species?

To investigate the functional conservation of C18orf32 across species, researchers can employ these comparative approaches:

• Sequence analysis methods:

  • Multiple sequence alignment of C18orf32 homologs from different species

  • Calculation of conservation scores for individual amino acid positions

  • Identification of conserved motifs that might indicate functional domains

  • Analysis of selective pressure (dN/dS ratios) to identify positions under evolutionary constraint

• Structural biology approaches:

  • Homology modeling based on available structural data

  • Prediction of secondary structure conservation across species

  • Analysis of conserved surface patches that might indicate interaction interfaces

• Expression pattern comparison:

  • Cross-species analysis of tissue expression patterns

  • Assessment of developmental expression timing in different model organisms

  • Analysis of regulatory elements controlling gene expression

• Functional complementation:

  • Rescue experiments in knockout models using homologs from different species

  • Assessment of whether the zebrafish homolog can functionally replace human C18orf32 in cellular assays

• Interactome conservation:

  • Comparison of protein interaction networks across species

  • Identification of conserved binding partners suggesting preserved functions

The availability of C18orf32 homologs in diverse species including mouse, rat, bovine, frog, zebrafish, chimpanzee, and chicken provides ample opportunity for comparative analyses across evolutionary distances.

How should researchers interpret variations in C18orf32 sequence and expression across species?

When analyzing cross-species variations in C18orf32, researchers should consider these interpretative frameworks:

• Sequence variation analysis:

  • Distinguish between conservative and non-conservative amino acid substitutions

  • Map variations to predicted functional domains or motifs

  • Consider covariation patterns that might indicate functionally linked residues

  • Analyze variation in the context of species-specific adaptations

• Expression pattern differences:

  • Correlate expression differences with species-specific physiological requirements

  • Consider tissue-specific adaptations that might drive expression variation

  • Analyze developmental timing differences in relation to species-specific developmental programs

• Evolutionary context:

  • Consider the evolutionary distance between species when interpreting conservation levels

  • Analyze lineage-specific duplications or losses that might affect functional interpretation

  • Examine synteny relationships to understand genomic context conservation

• Functional implications:

  • For highly conserved regions, infer critical functional importance

  • For variable regions, consider species-specific functional adaptations

  • Use variation data to design targeted mutagenesis experiments

• Technical considerations:

  • Ensure the completeness and accuracy of sequence data across species

  • Account for annotation differences in genomic databases

  • Consider isoform variations that might complicate direct comparisons

The identification of multiple protein isoforms in prairie vole (XP_005356325.1, XP_005356327.1, XP_005356326.1) suggests potentially complex patterns of alternative splicing that may vary across species, adding another layer to comparative analyses.